These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36845978)

  • 1. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.
    Dickson-Gomez J; Weeks M; Green D; Boutouis S; Galletly C; Christenson E
    Drug Alcohol Depend Rep; 2022 Jun; 3():100051. PubMed ID: 36845978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act.
    Andrews CM; Grogan CM; Smith BT; Abraham AJ; Pollack HA; Humphreys K; Westlake MA; Friedmann PD
    Health Aff (Millwood); 2018 Aug; 37(8):1216-1222. PubMed ID: 30080460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.
    Knudsen HK; Lofwall MR; Havens JR; Walsh SL
    Drug Alcohol Depend; 2015 Dec; 157():36-43. PubMed ID: 26483356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit requirements for substance use disorder treatment in state health insurance exchanges.
    Tran Smith B; Seaton K; Andrews C; Grogan CM; Abraham A; Pollack H; Friedmann P; Humphreys K
    Am J Drug Alcohol Abuse; 2018; 44(4):426-430. PubMed ID: 29261341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment.
    Crable EL; Benintendi A; Jones DK; Walley AY; Hicks JM; Drainoni ML
    Implement Sci; 2022 Jan; 17(1):3. PubMed ID: 34991638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of patients with substance use disorder before and after the Affordable Care Act.
    Campbell CI; Parthasarathy S; Altschuler A; Young-Wolff KC; Satre DD
    Drug Alcohol Depend; 2018 Dec; 193():124-130. PubMed ID: 30366189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021.
    Shoulders A; Andrews CM; Westlake MA; Abraham AJ; Grogan CM
    JAMA Health Forum; 2023 Aug; 4(8):e232502. PubMed ID: 37566428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Mental Health Parity and Addiction Equity Act on Specialty Outpatient Behavioral Health Spending and Utilization.
    Gertner AK; Rotter J; Cruden G
    J Ment Health Policy Econ; 2018 Sep; 21(3):91-103. PubMed ID: 30530870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study.
    Treitler P; Enich M; Bowden C; Mahone A; Lloyd J; Crystal S
    J Subst Use Addict Treat; 2024 Jan; 156():209212. PubMed ID: 37935350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators.
    O'Malley DM; Abraham CM; Lee HS; Rubinstein EB; Howard J; Hudson SV; Kieber-Emmons AM; Crabtree BF
    Fam Pract; 2022 Mar; 39(2):282-291. PubMed ID: 34423366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of federal parity on substance use disorder treatment.
    Busch SH; Epstein AJ; Harhay MO; Fiellin DA; Un H; Leader D; Barry CL
    Am J Manag Care; 2014; 20(1):76-82. PubMed ID: 24512166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Utilization and Health Among Low-Income Adults After Medicaid Expansion or Expanded Private Insurance.
    Sommers BD; Blendon RJ; Orav EJ; Epstein AM
    JAMA Intern Med; 2016 Oct; 176(10):1501-1509. PubMed ID: 27532694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?
    Malik AT; Alexander J; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2021 Mar; 479(3):493-502. PubMed ID: 32805094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers.
    Knudsen HK; Studts JL
    J Psychoactive Drugs; 2017; 49(2):111-121. PubMed ID: 28296579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Federal Parity In The Evolving Mental Health And Addiction Care Landscape.
    Barry CL; Goldman HH; Huskamp HA
    Health Aff (Millwood); 2016 Jun; 35(6):1009-16. PubMed ID: 27269016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
    Johnson NL; Choi S; Herrera CN
    J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.